The store will not work correctly when cookies are disabled.
4-(2,2-dimethylbutanoyl)-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one
ID: ALA2287729
PubChem CID: 76323831
Max Phase: Preclinical
Molecular Formula: C23H30O3
Molecular Weight: 354.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCC(C)(C)C(=O)C1=C(c2c(C)cc(C)cc2C)C(=O)OC12CCCC2
Standard InChI: InChI=1S/C23H30O3/c1-7-22(5,6)20(24)19-18(17-15(3)12-14(2)13-16(17)4)21(25)26-23(19)10-8-9-11-23/h12-13H,7-11H2,1-6H3
Standard InChI Key: OVMTZOQVXGUVGE-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
20.2384 -11.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9921 -11.5933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9238 -10.7786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1278 -10.5918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7043 -11.2911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3218 -12.0886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3206 -12.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0287 -13.3171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7383 -12.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7355 -12.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0269 -11.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0244 -10.8626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6126 -13.3162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4467 -13.3152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4418 -11.6736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2125 -11.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2352 -10.6192 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4538 -10.8585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8004 -10.3677 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4497 -12.7233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2329 -13.5084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2668 -12.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6842 -13.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6665 -12.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0819 -12.7119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4915 -13.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
11 12 1 0
7 13 1 0
9 14 1 0
10 15 1 0
15 16 2 0
16 5 1 0
5 17 1 0
17 18 1 0
18 15 1 0
18 19 2 0
16 20 1 0
20 21 2 0
20 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
25 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.49 | Molecular Weight (Monoisotopic): 354.2195 | AlogP: 5.24 | #Rotatable Bonds: 4 |
Polar Surface Area: 43.37 | Molecular Species: ┄ | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 7.03 | CX LogD: 7.03 |
Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.69 | Np Likeness Score: 0.20 |
References
1. Zhao JH, Wang ZC, Ji MH, Cheng JL, Zhu GN, Yu CM.. (2012) Synthesis and bioactivity evaluation of novel spiromesifen derivatives., 68 (1): [PMID:21997953] [10.1002/ps.2248] |